- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有40家主力机构披露2025-06-30报告期持股数据，持仓量总计1.87亿股，占流通A股46.53%
- 波段诊断：
-
技术面诊股
诊断结果：4.0技术面打败了35%的股票
技术面评分前10的股票
近期的平均成本为9.94元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为9.94元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"9.94","date":1764750183,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。
[{"date":"2025.12.04","stock":"-1.79","trade":null,"ind":"0.40"},{"date":"2025.12.03","stock":"-1.08","trade":null,"ind":"-0.78"},{"date":"2025.12.02","stock":"0.10","trade":null,"ind":"-0.68"},{"date":"2025.12.01","stock":"-0.29","trade":null,"ind":"1.25"},{"date":"2025.11.28","stock":"0.89","trade":null,"ind":"0.85"},{"date":"2025.11.27","stock":"-0.20","trade":null,"ind":"-0.25"},{"date":"2025.11.26","stock":"-0.20","trade":null,"ind":"1.02"},{"date":"2025.11.25","stock":"0.59","trade":null,"ind":"1.53"},{"date":"2025.11.24","stock":"2.96","trade":null,"ind":"0.37"},{"date":"2025.11.21","stock":"-4.66","trade":null,"ind":"-3.41"},{"date":"2025.11.20","stock":"-0.96","trade":null,"ind":"-0.76"},{"date":"2025.11.19","stock":"-2.26","trade":null,"ind":"-0.00"},{"date":"2025.11.18","stock":"-0.84","trade":null,"ind":"-0.92"},{"date":"2025.11.17","stock":"-3.51","trade":null,"ind":"-0.11"},{"date":"2025.11.14","stock":"1.37","trade":null,"ind":"-1.93"},{"date":"2025.11.13","stock":"0.55","trade":null,"ind":"1.78"},{"date":"2025.11.12","stock":"1.68","trade":null,"ind":"-0.36"},{"date":"2025.11.11","stock":"-0.09","trade":null,"ind":"-1.03"},{"date":"2025.11.10","stock":"1.23","trade":null,"ind":"0.18"},{"date":"2025.11.07","stock":"-2.66","trade":null,"ind":"-0.36"},{"date":"2025.11.06","stock":"-1.98","trade":null,"ind":"1.73"}]
易瑞生物,深证成指,医疗器械指数
压力支撑
该股压力位为9.93元，支撑位为9.78元。
[{"text":"\u538b\u529b\u4f4d","value":"9.93","date":1764777600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"9.78","date":1764777600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：6.9资金面打败了95%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：12月04日 20:30
| 机构今日流向(万元) | -308.16 | 机构5日流向(万元) | -2271.50 |
| 机构10日流向(万元) | -4287.29 | 机构20日流向(万元) | -11020.98 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加722.42万股，其中基金净减仓2家，主力净增仓11家，请投资者中长期谨慎为宜。
截止2025-06-30，共40家主力机构（基金35家，一般法人5家），持仓量总计18672.69万股，占流通A股46.53%
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：2家 ，减持 7.21万股
新出现在主力名单中：30家 ，持有920.3万股
从主力名单中消失：19家 ，原持有91.98万股
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：2家 ，减持 7.21万股
新出现在主力名单中：30家 ，持有920.3万股
从主力名单中消失：19家 ，原持有91.98万股
消息面诊股
诊断结果：5.5消息面打败了43%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 易瑞生物：12月3日获融资买入200.58万元
2025-12-04 - 易瑞生物(12月3日)出现1笔大宗交易
2025-12-03 - 易瑞生物：12月2日获融资买入489.42万元
2025-12-03 - 易瑞生物(12月2日)出现1笔大宗交易
2025-12-02 - 易瑞生物：12月1日获融资买入206.30万元
2025-12-02 - 易瑞生物(12月1日)出现1笔大宗交易
2025-12-01 - 易瑞生物：11月28日获融资买入370.50万元
2025-12-01 - 易瑞生物：公司股东人数将在定期报告中进行披露
2025-11-28 - 易瑞生物今日大宗交易折价成交57万股，成交额501
2025-11-28 - 易瑞生物(11月28日)出现1笔大宗交易
2025-11-28
消息列表
| 一般消息 | 募资投向 | 公司出售资产 | 2025-10-09 |
| 一般消息 | 募资投向 | 预测年新增净利润为:3399.1... | 2025-09-19 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-15 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
| 利好 | 分红转增 | 10派0.174399元(含税) | 2025-04-25 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-04-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-27 |
| 利好 | 业绩预告 | 预计扭亏 | 2025-01-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-12-19 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了4%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2025.12.04","price":"0.40","value":null},{"date":"2025.12.03","price":"-0.78","value":null},{"date":"2025.12.02","price":"-0.68","value":null},{"date":"2025.12.01","price":"1.25","value":null},{"date":"2025.11.28","price":"0.85","value":null},{"date":"2025.11.27","price":"-0.25","value":null},{"date":"2025.11.26","price":"1.02","value":null},{"date":"2025.11.25","price":"1.53","value":null},{"date":"2025.11.24","price":"0.37","value":null},{"date":"2025.11.21","price":"-3.41","value":null},{"date":"2025.11.20","price":"-0.76","value":null},{"date":"2025.11.19","price":"-0.00","value":null},{"date":"2025.11.18","price":"-0.92","value":null},{"date":"2025.11.17","price":"-0.11","value":null},{"date":"2025.11.14","price":"-1.93","value":null},{"date":"2025.11.13","price":"1.78","value":null},{"date":"2025.11.12","price":"-0.36","value":null},{"date":"2025.11.11","price":"-1.03","value":null},{"date":"2025.11.10","price":"0.18","value":null},{"date":"2025.11.07","price":"-0.36","value":null},{"date":"2025.11.06","price":"1.73","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 热景生物 | 28.41% | 2.58% | 5.3分 |
| 2 | 中源协和 | 16.42% | 1.05% | 5.6分 |
| 3 | 中红医疗 | 13.59% | 4.82% | 6.0分 |
| 4 | 康众医疗 | 12.21% | 8.78% | 5.9分 |
| 5 | 国发股份 | 11.97% | 0.63% | 5.1分 |
| 6 | 英科医疗 | 11.54% | 3.56% | 6.1分 |
| 8 | 佰仁医疗 | 9.00% | -3.89% | 4.6分 |
| 10 | 华兰股份 | 6.82% | -1.74% | 4.8分 |
| 12 | 鱼跃医疗 | 3.40% | 1.94% | 6.1分 |
| 14 | 海利生物 | 1.44% | 3.82% | 5.3分 |
| 16 | 万东医疗 | 0.95% | -1.84% | 4.9分 |
| 18 | 基蛋生物 | 0.24% | 0.84% | 5.8分 |
| 20 | 凯普生物 | -0.17% | -1.18% | 4.1分 |
| 22 | 可孚医疗 | -0.74% | 5.52% | 6.4分 |
| 24 | 奥美医疗 | -0.95% | -0.69% | 5.0分 |
| 26 | 健帆生物 | -1.34% | -1.00% | 4.5分 |
| 28 | 东方海洋 | -1.54% | 0.39% | 4.7分 |
| 30 | 东星医疗 | -1.93% | -2.05% | 3.8分 |
| 32 | 拱东医疗 | -2.03% | -1.15% | 5.3分 |
| 34 | 美康生物 | -2.27% | -2.09% | 3.5分 |
| 36 | 迈瑞医疗 | -2.44% | 1.88% | 5.6分 |
| 38 | 理邦仪器 | -2.52% | -2.59% | 4.9分 |
| 40 | 大博医疗 | -2.64% | 0.46% | 5.6分 |
| 42 | ST凯利 | -3.10% | -2.76% | 4.3分 |
| 44 | 维力医疗 | -3.26% | 0.07% | 5.6分 |
| 46 | 新产业 | -3.50% | 2.63% | 4.8分 |
| 48 | 昊海生科 | -3.61% | -1.16% | 4.6分 |
| 50 | 爱博医疗 | -3.75% | 1.44% | 5.4分 |
| 52 | 爱迪特 | -3.90% | -0.23% | 5.2分 |
| 54 | 康泰医学 | -4.12% | -5.44% | 3.4分 |
| 56 | 天益医疗 | -4.26% | -5.83% | 4.4分 |
| 58 | 奕瑞科技 | -4.50% | -0.79% | 5.2分 |
| 60 | 三鑫医疗 | -4.59% | -1.19% | 4.7分 |
| 62 | 赛科希德 | -4.59% | -0.91% | 4.2分 |
| 64 | 南微医学 | -4.68% | 1.11% | 5.5分 |
| 66 | 科美诊断 | -4.71% | -2.66% | 4.0分 |
| 68 | 华强科技 | -4.81% | -3.55% | 3.6分 |
| 70 | 东方生物 | -4.88% | -4.58% | 4.0分 |
| 72 | 宝莱特 | -5.36% | -2.70% | 4.5分 |
| 74 | 艾德生物 | -5.51% | -0.59% | 4.4分 |
| 76 | 康德莱 | -5.65% | -0.11% | 5.2分 |
| 78 | 济民健康 | -6.16% | -5.11% | 3.5分 |
| 80 | 安图生物 | -6.41% | -2.26% | 5.1分 |
| 82 | 三诺生物 | -6.58% | -2.91% | 5.2分 |
| 84 | 康拓医疗 | -6.91% | -1.60% | 5.5分 |
| 86 | 海泰新光 | -7.09% | 0.11% | 5.6分 |
| 88 | 开立医疗 | -7.38% | -2.55% | 4.4分 |
| 90 | 迈普医学 | -7.98% | -4.99% | 4.3分 |
| 92 | 西山科技 | -8.06% | -3.25% | 3.9分 |
| 94 | 圣湘生物 | -8.28% | -1.63% | 4.8分 |
| 96 | 安必平 | -9.03% | -5.18% | 3.5分 |
| 98 | 麦克奥迪 | -9.16% | 2.43% | 5.1分 |
| 100 | 海尔生物 | -9.23% | -0.68% | 4.9分 |
| 102 | 乐普医疗 | -9.32% | -1.32% | 4.9分 |
| 104 | 硕世生物 | -10.07% | -1.78% | 5.0分 |
| 106 | 爱朋医疗 | -10.44% | 2.57% | 4.9分 |
| 108 | 麦澜德 | -10.55% | -0.88% | 5.1分 |
| 110 | 天智航 | -10.92% | -3.38% | 4.6分 |
| 112 | 春立医疗 | -11.22% | -0.53% | 5.4分 |
| 114 | 福瑞股份 | -12.02% | -2.21% | 4.8分 |
| 116 | 赛诺医疗 | -12.42% | -4.60% | 4.7分 |
| 118 | 微电生理 | -12.66% | -2.27% | 4.0分 |
| 120 | 山外山 | -13.79% | -4.35% | 4.3分 |
| 122 | 爱威科技 | -15.23% | -3.27% | 5.5分 |
| 124 | 万泰生物 | -15.48% | -5.24% | 4.0分 |
| 126 | - | -16.64% | -5.56% | 分 |
| 128 | - | -17.79% | -2.72% | 分 |
| 130 | - | -19.58% | -4.82% | 分 |
| 132 | 振德医疗 | -26.16% | -6.94% | 5.2分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 81/245 ， 43/245。
[{"date":"2025-09-30","value":"2.03","vol":"2.86"},{"date":"2025-06-30","value":"0.27","vol":"2.27"},{"date":"2025-03-31","value":"-0.39","vol":"1.15"},{"date":"2024-12-31","value":"1.99","vol":"0.53"},{"date":"2024-09-30","value":"0.46","vol":"4.71"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.03 | 0.27 | -0.39 | 1.99 | 0.46 |
| 行业(%) | 2.86 | 2.27 | 1.15 | 0.53 | 4.71 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"64.30","vol":"51.79"},{"date":"2025-06-30","value":"64.47","vol":"52.10"},{"date":"2025-03-31","value":"52.37","vol":"51.81"},{"date":"2024-12-31","value":"70.63","vol":"52.63"},{"date":"2024-09-30","value":"66.09","vol":"53.49"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
64.30 | 64.47 | 52.37 | 70.63 | 66.09 |
| 行业(%) | 51.79 | 52.10 | 51.81 | 52.63 | 53.49 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 17/245 ， 2/245。
[{"date":"2025-09-30","value":"17.45","vol":"-0.61"},{"date":"2025-06-30","value":"5.44","vol":"-1.71"},{"date":"2025-03-31","value":"35.28","vol":"-0.92"},{"date":"2024-12-31","value":"-11.75","vol":"0.64"},{"date":"2024-09-30","value":"-4.27","vol":"0.79"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
17.45 | 5.44 | 35.28 | -11.75 | -4.27 |
| 行业(%) | -0.61 | -1.71 | -0.92 | 0.64 | 0.79 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"362.49","vol":"-18.69"},{"date":"2025-06-30","value":"250.02","vol":"-20.27"},{"date":"2025-03-31","value":"52.95","vol":"-4.25"},{"date":"2024-12-31","value":"109.26","vol":"-24.11"},{"date":"2024-09-30","value":"103.93","vol":"-20.23"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
362.49 | 250.02 | 52.95 | 109.26 | 103.93 |
| 行业(%) | -18.69 | -20.27 | -4.25 | -24.11 | -20.23 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 104/245 ， 69/245。
[{"date":"2025-09-30","value":"0.13","vol":"0.25"},{"date":"2025-06-30","value":"0.08","vol":"0.17"},{"date":"2025-03-31","value":"0.03","vol":"0.08"},{"date":"2024-12-31","value":"0.16","vol":"0.35"},{"date":"2024-09-30","value":"0.12","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.13 | 0.08 | 0.03 | 0.16 | 0.12 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.35 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.35","vol":"1.67"},{"date":"2025-06-30","value":"0.83","vol":"1.13"},{"date":"2025-03-31","value":"0.58","vol":"0.55"},{"date":"2024-12-31","value":"1.83","vol":"2.33"},{"date":"2024-09-30","value":"1.53","vol":"1.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.35 | 0.83 | 0.58 | 1.83 | 1.53 |
| 行业(次) | 1.67 | 1.13 | 0.55 | 2.33 | 1.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"10.28","vol":"14.91"},{"date":"2025-06-30","value":"2.33","vol":"15.06"},{"date":"2025-03-31","value":"-2.87","vol":"4.01"},{"date":"2024-12-31","value":"27.53","vol":"29.57"},{"date":"2024-09-30","value":"2.05","vol":"15.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 10.28 | 2.33 | -2.87 | 27.53 | 2.05 |
| 行业 | 14.91 | 15.06 | 4.01 | 29.57 | 15.40 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.67","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"7.56","vol":"2.19"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.67 | - | 7.56 | - |
| 行业 | 0.00 | 1.57 | 0.00 | 2.19 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 81/245 ， 86/245。
[{"date":"2025-09-30","value":"5.16","vol":"5.68"},{"date":"2025-06-30","value":"6.41","vol":"5.50"},{"date":"2025-03-31","value":"5.47","vol":"5.89"},{"date":"2024-12-31","value":"4.95","vol":"5.34"},{"date":"2024-09-30","value":"5.17","vol":"5.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
5.16 | 6.41 | 5.47 | 4.95 | 5.17 |
| 行业 | 5.68 | 5.50 | 5.89 | 5.34 | 5.92 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"4.66","vol":"4.56"},{"date":"2025-06-30","value":"5.78","vol":"4.40"},{"date":"2025-03-31","value":"5.00","vol":"4.77"},{"date":"2024-12-31","value":"4.58","vol":"4.32"},{"date":"2024-09-30","value":"4.77","vol":"4.78"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
4.66 | 5.78 | 5.00 | 4.58 | 4.77 |
| 行业 | 4.56 | 4.40 | 4.77 | 4.32 | 4.78 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 11/245 ， 15/245。
[{"date":"2025-09-30","value":"38.55","vol":"22.06"},{"date":"2025-06-30","value":"39.06","vol":"22.01"},{"date":"2025-03-31","value":"39.97","vol":"21.24"},{"date":"2024-12-31","value":"40.28","vol":"21.92"},{"date":"2024-09-30","value":"38.08","vol":"20.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
38.55 | 39.06 | 39.97 | 40.28 | 38.08 |
| 行业(%) | 22.06 | 22.01 | 21.24 | 21.92 | 20.92 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.63","vol":"0.72"},{"date":"2025-06-30","value":"0.64","vol":"0.58"},{"date":"2025-03-31","value":"0.67","vol":"0.57"},{"date":"2024-12-31","value":"0.68","vol":"0.55"},{"date":"2024-09-30","value":"0.62","vol":"0.38"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.63 | 0.64 | 0.67 | 0.68 | 0.62 |
| 行业(%) | 0.72 | 0.58 | 0.57 | 0.55 | 0.38 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"2.37","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.83","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-1.85","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.17","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.25","blueLineValue":"0.06","type":"YC"}]